Cite
HARVARD Citation
Gadgeel, S. et al. (2017). Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study. Lung cancer. pp. 101-108. [Online].